We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOC icon
476
Healthpeak Properties
DOC
$15.1B
$2.24M 0.01%
97,983
+5,872
+6% +$127K
LEN icon
477
Lennar Class A
LEN
$19.8B
$2.24M 0.01%
12,325
+4,170
+51% +$699K
OXY icon
478
Occidental Petroleum
OXY
$56.8B
$2.21M 0.01%
42,941
+2,479
+6% +$141K
K
479
DELISTED
Kellanova
K
$2.21M 0.01%
27,391
-10,310
-27% -$734K
GLW icon
480
Corning
GLW
$119B
$2.2M 0.01%
48,662
-3,448
-7% -$145K
FDS icon
481
Factset
FDS
$9.36B
$2.19M 0.01%
4,772
-268
-5% -$114K
PFG icon
482
Principal Financial Group
PFG
$24.3B
$2.16M 0.01%
25,168
+1,142
+5% +$92.2K
CLX icon
483
Clorox
CLX
$11.6B
$2.15M 0.01%
13,197
-560
-4% -$83K
AXON
484
Axon Enterprise
AXON
$42.5B
$2.07M 0.01%
5,169
+113
+2% +$39K
ENS icon
485
EnerSys
ENS
$6.78B
$1.99M 0.01%
+19,536
New +$1.97M
RJF icon
486
Raymond James Financial
RJF
$33.8B
$1.96M 0.01%
16,043
+2,376
+17% +$278K
ADM icon
487
Archer Daniels Midland
ADM
$38.2B
$1.96M 0.01%
32,744
+709
+2% +$43.2K
JBHT icon
488
JB Hunt Transport Services
JBHT
$25.5B
$1.95M 0.01%
11,337
+1,146
+11% +$193K
CHTR icon
489
Charter Communications
CHTR
$17.3B
$1.95M 0.01%
6,022
+416
+7% +$140K
SBRA icon
490
Sabra Healthcare REIT
SBRA
$5.34B
$1.94M 0.01%
+104,489
New +$1.76M
ENPH icon
491
Enphase Energy
ENPH
$4.96B
$1.92M 0.01%
17,012
+7,926
+87% +$886K
CDW icon
492
CDW
CDW
$18.9B
$1.92M 0.01%
8,463
– –
GPN icon
493
Global Payments
GPN
$23B
$1.9M 0.01%
18,576
+117
+0.6% +$12.1K
HPE icon
494
Hewlett Packard
HPE
$63.4B
$1.9M 0.01%
92,836
-16,983
-15% -$325K
MNST icon
495
Monster Beverage
MNST
$94.3B
$1.89M 0.01%
36,216
+3,653
+11% +$181K
ZBH icon
496
Zimmer Biomet
ZBH
$18.2B
$1.88M 0.01%
17,433
+724
+4% +$79K
COIN icon
497
Coinbase
COIN
$38.6B
$1.87M 0.01%
10,501
-5
-0% -$1K
MRO
498
DELISTED
Marathon Oil Corporation
MRO
$1.86M 0.01%
69,855
+5,022
+8% +$139K
WST icon
499
West Pharmaceutical
WST
$24B
$1.85M 0.01%
6,152
+434
+8% +$133K
HUBS icon
500
HubSpot
HUBS
$12.2B
$1.83M 0.01%
3,442
+259
+8% +$130K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.